Prenatal Diagnosis of Congenital Adrenal Hyperplasia Caused by P450 Oxidoreductase Deficiency
Author(s) -
Nicole Reisch,
Jan Idkowiak,
Beverly Hughes,
Hannah E Ivison,
Omar AbdulRahman,
Laura G. Hendon,
Ann Haskins Olney,
Shelly Nielsen,
Rachel Harrison,
Edward Blair,
Vivek Dhir,
Nils Krone,
Cedric Shackleton,
Wiebke Arlt
Publication year - 2013
Publication title -
the journal of clinical endocrinology and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.206
H-Index - 353
eISSN - 1945-7197
pISSN - 0021-972X
DOI - 10.1210/jc.2012-3449
Subject(s) - congenital adrenal hyperplasia , virilization , medicine , endocrinology , pregnancy , estriol , fetus , androgen excess , androgen , biology , polycystic ovary , diabetes mellitus , estrogen , hormone , genetics , insulin resistance
Mutations in the electron donor enzyme P450 oxidoreductase (POR) result in congenital adrenal hyperplasia with apparent combined 17α-hydroxylase/17,20 lyase and 21-hydroxylase deficiencies, also termed P450 oxidoreductase deficiency (PORD). Major clinical features present in PORD are disordered sex development in affected individuals of both sexes, glucocorticoid deficiency, and multiple skeletal malformations.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom